Moreover, interleukins like IL-2 interact with TGF-β in immune signaling; IL-2, along with TGF-β produced by tumor cells, promotes the generation of regulatory T cells (Treg), which generally counteract anti-tumor immunity. Here, TGFB1 is linked to neoplasm.